Healthcare provider profile · identity verified

William S. Scott, MD

Family Practice · FONTANA, CA · NPI 1043387921

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	872	289
Amlodipine Besylate	Amlodipine Besylate	511	179
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	485	92
Lisinopril	Lisinopril	380	120
Levothyroxine Sodium	Levothyroxine Sodium	364	116
Losartan Potassium	Losartan Potassium	334	120
Potassium Chloride	Potassium Chloride	324	119
Omeprazole	Omeprazole	273	92
Furosemide	Furosemide	263	101
Pantoprazole Sodium	Pantoprazole Sodium	234	79
Tamsulosin Hcl	Tamsulosin Hcl	223	79
Albuterol Sulfate Hfa	Albuterol Sulfate	209	94
Metformin Hcl Er	Metformin Hcl	204	77
Meloxicam	Meloxicam	203	71
Metoprolol Tartrate	Metoprolol Tartrate	199	67
Rosuvastatin Calcium	Rosuvastatin Calcium	198	70
Glipizide	Glipizide	188	72
Atenolol	Atenolol	184	57
Ibuprofen	Ibuprofen	171	63
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	163	26
Simvastatin	Simvastatin	159	54
Gabapentin	Gabapentin	157	60
Metformin Hcl	Metformin Hcl	157	54
Trazodone Hcl	Trazodone Hcl	147	41
Ozempic	Semaglutide	144	28
Lorazepam	Lorazepam	116	29
Alendronate Sodium	Alendronate Sodium	113	39
Bisoprolol Fumarate	Bisoprolol Fumarate	113	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	42
Baclofen	Baclofen	111	27
Pradaxa	Dabigatran Etexilate Mesylate	109	31
Wixela Inhub	Fluticasone Propion/Salmeterol	105	40
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	103	36
Ezetimibe	Ezetimibe	99	30
Prednisone	Prednisone	99	71
Sertraline Hcl	Sertraline Hcl	97	37
Clopidogrel	Clopidogrel Bisulfate	95	32
Hydrochlorothiazide	Hydrochlorothiazide	87	28
Buspirone Hcl	Buspirone Hcl	83	21
Fluticasone Propionate	Fluticasone Propionate	83	33
Pioglitazone Hcl	Pioglitazone Hcl	78	27
Tramadol Hcl	Tramadol Hcl	78	32
Triamcinolone Acetonide	Triamcinolone Acetonide	78	37
Azelastine Hcl	Azelastine Hcl	75	28
Jardiance	Empagliflozin	74	24
Terazosin Hcl	Terazosin Hcl	72	25
Montelukast Sodium	Montelukast Sodium	71	21
Solifenacin Succinate	Solifenacin Succinate	71	25
Cephalexin	Cephalexin	69	49
Alprazolam	Alprazolam	68	11
Clonazepam	Clonazepam	67	suppressed
Allopurinol	Allopurinol	66	21
Spiriva Respimat	Tiotropium Bromide	65	15
Duloxetine Hcl	Duloxetine Hcl	62	19
Spironolactone	Spironolactone	62	23
Eliquis	Apixaban	61	16
Morphine Sulfate Er	Morphine Sulfate	60	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	20
Carvedilol	Carvedilol	58	22
Finasteride	Finasteride	57	19
Hydralazine Hcl	Hydralazine Hcl	56	21
Temazepam	Temazepam	56	suppressed
Famotidine	Famotidine	53	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	13
Fluocinonide	Fluocinonide	51	33
Humulin R	Insulin Regular, Human	51	14
Ondansetron Odt	Ondansetron	51	15
Acetaminophen-Codeine	Acetaminophen With Codeine	49	13
Mirtazapine	Mirtazapine	49	18
Humulin N	Insulin Nph Human Isophane	48	17
Ondansetron Hcl	Ondansetron Hcl	48	suppressed
Topiramate	Topiramate	46	12
Donepezil Hcl	Donepezil Hcl	45	13
Estradiol	Estradiol	45	23
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	45	15
Lactulose	Lactulose	43	suppressed
Cefuroxime	Cefuroxime Axetil	40	32
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	39	11
Celecoxib	Celecoxib	38	12
Fenofibrate	Fenofibrate	38	11
Alvesco	Ciclesonide	37	19
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	36	36
Methenamine Hippurate	Methenamine Hippurate	35	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	35	12
Nitroglycerin	Nitroglycerin	33	17
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Amoxicillin	Amoxicillin	29	23
Victoza 3-Pak	Liraglutide	29	suppressed
Colchicine	Colchicine	28	11
Hydrocortisone	Hydrocortisone	28	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Liraglutide	Liraglutide	27	suppressed
Testosterone	Testosterone	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	21
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Victoza 2-Pak	Liraglutide	25	13
Acyclovir	Acyclovir	24	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	24	11
Digoxin	Digoxin	24	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	24	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	23	23
Ciclopirox	Ciclopirox	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	19
Latanoprost	Latanoprost	23	suppressed
Azithromycin	Azithromycin	22	20
Nifedipine Er	Nifedipine	22	suppressed
Trospium Chloride	Trospium Chloride	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Nabumetone	Nabumetone	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Retin-A	Tretinoin	19	suppressed
Risedronate Sodium	Risedronate Sodium	19	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Primidone	Primidone	18	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Nystatin	Nystatin	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Minoxidil	Minoxidil	16	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	13
Humalog	Insulin Lispro	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	12	12
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Epinephrine	Epinephrine	12	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	11	suppressed
Naproxen	Naproxen	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error